NCT01470339View on ClinicalTrials.gov

Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Pain
Interventions
DRUG

duloxetine

duloxetine 60mg once a day for 5 weeks

Trial Locations (1)

Unknown

MRI center, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT01470339 - Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile | Biotech Hunter | Biotech Hunter